BBS Council

  • Hans Ulrich Burger, F. Hoffmann-La Roche Ltd (President)
  • Fred Sorenson, Xcenda (Treasurer)
  • Marisa Bacchi, Actelion Pharmaceuticals Ltd
  • Marco Cattaneo, University of Basel
  • Lilla Di Scala, Actelion Pharmaceuticals Ltd
  • Achim Guettner, Novartis Pharma AG
  • Dominik Heinzmann, F. Hoffmann-La Roche Ltd
  • Roland Marion-Gallois, Celgene
  • Giusi Moffa, University of Basel
  • Amanda Ross, Swiss Tropical and Public Health Institute
  • Kaspar Rufibach, F. Hoffmann-La Roche Ltd
  • Juliane Schaefer, F. Hoffmann-La Roche Ltd
  • Marc Vandemeulebroecke, Novartis Pharma AG
  • Pierre Verweij, Idorsia Pharmaceuticals Ltd
  • Simon Wandel, Novartis Pharma AG
  • Marcel Wolbers, F. Hoffmann-La Roche Ltd

BBS Purpose
The Basel Biometric Section is part of the ROeS, the Austrian Swiss Region of the International Biometric Society (IBS). BBS is an independent, non-profit organization which provides a forum for discussions of how to apply statistical methods in biological and medical science.


Sorry, the comment form is closed at this time.